Medical Communications

Showing 15 posts of 6402 posts found.

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 7, 2020 Medical Communications COVID-19, Top 10 news, top 10

The top ten news stories this week are dominated by corporate scandals, with researchers finding that Coca-Cola paid an organisation …
morris

Humanigen appoints Timothy Morris as Chief Operating Officer and Chief Financial Officer

August 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Humanigen have appointed Timothy E. Morris to its newly created role of Chief Operating Officer and Chief Financial Officer and …
chrissy

Medipharma appoints Former President of Janssen Chris Halyk to its Board of Directors

August 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Medipharma has appointed Chris Halyk, the former President of Janssen, to its Board of Directors. This is the third appointment …
enoch_kariuki

VelosBio reveals new Chief Financial Officer

August 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing VelosBio, appointment

Dr Enoch Kariuki has been named as the new Chief Financial Officer at biopharma firm VelosBio, where he will assume …
1

CAR T cell therapy is revolutionising cancer treatment, but at what cost?

August 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature

CAR T cell therapy is one of the latest innovations in gene therapy. The process is primarily used to treat …
shutterstock_138095450

US Government commits $2.1bn to GSK and Sanofi’s COVID-19 vaccine candidate

July 31, 2020 Medical Communications, Research and Development COVID-19, GSK, Sanofi, US, Vaccine

The US Government has announced additional funding into Sanofi and GlaxSmithKline’s efforts to develop a recombinant protein-based vaccine to the …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 31, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Roche, UK government, Vaccine, lilly, pharma, top 10

Another week dominated by COVID-19. Among our most popular stories this week, Celltrion’s infliximab biosimilar Remsima has scored approval for …
shutterstock_2

Japan reserves 120m doses of BioNTech’s COVID-19 vaccine

July 31, 2020 Manufacturing and Production, Medical Communications BioNTech, COVID-19, Japan, Vaccine, pharma

Japan’s Ministry of Health, Labour and Welfare (MHLW) has sealed a deal with Pfizer and BioNTech to secure 120 million …
janssen_latest_logo_on_sign

FDA expands Stelara indication to cover paediatric plaque psoriasis

July 31, 2020 Medical Communications, Sales and Marketing Janssen, Stelara, pharma, plaque psoriasis

Janssen’s IL-12 and IL-23 inhibitor Stelara (ustekinumab) has had its approved indications expanded by the FDA to include the treatment …
nice_reception

Bavencio+Inylta combo approved or Cancer Drugs Fund in advanced renal cell carcinoma

July 31, 2020 Medical Communications, Sales and Marketing Merck, NICE, Pfizer, pharma

NICE has revealed that a combination of Merck KGaA’s Bavencio (avelumab) and Pfizer’s Inlyta (axitinib) will be made available as …

Takeda poised to cut sales jobs in Japan as restructuring continues

July 29, 2020 Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, job cuts

Japan’s biggest drug firm Takeda is said to be mulling plans to cut back its sales operations with a new …
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

July 29, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The once-touted COVID cure hydroxychloroquine continues its downward spiral of credibility as new data is published on its lack of …
glenmark

Glenmark’s favipiravir accelerates viral clearance and clinical recovery in COVID-19 patients

July 24, 2020 Medical Communications, Research and Development COVID-19, coronavirus, favipiravir; Glenmark

The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …
indianapolis

Eli Lilly asks for a $24 million tax break for diabetes care facility expansion in Indianapolis

July 24, 2020 Medical Communications Eli Lilly, Humalog, diabetes, insulin

Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into …

UCB’s investigational IL-17A and IL-17F inhibitor outclasses Novartis’ Cosentyx in plaque psoriasis

July 24, 2020 Medical Communications, Research and Development Cosentyx, UCB, pharma, psoriasis

UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …
The Gateway to Local Adoption Series

Latest content